276 related articles for article (PubMed ID: 31087664)
1. Molecular basis for and chemogenetic modulation of comorbidities in GABRG2-deficient epilepsies.
Zhang CQ; McMahon B; Dong H; Warner T; Shen W; Gallagher M; Macdonald RL; Kang JQ
Epilepsia; 2019 Jun; 60(6):1137-1149. PubMed ID: 31087664
[TBL] [Abstract][Full Text] [Related]
2. 4-Phenylbutyrate promoted wild-type γ-aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2
Shen W; Flamm C; Delahanty AJ; Casteel E; Biven M; DeLeeuw MB; Poliquin S; Nwosu G; Randhave K; Kang JQ
Epilepsia; 2024 Jan; 65(1):204-217. PubMed ID: 37746768
[TBL] [Abstract][Full Text] [Related]
3. Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2
Huang X; Zhou C; Tian M; Kang JQ; Shen W; Verdier K; Pimenta A; MacDonald RL
Epilepsia; 2017 Aug; 58(8):1451-1461. PubMed ID: 28586508
[TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum stress increases inflammatory cytokines in an epilepsy mouse model Gabrg2
Shen W; Poliquin S; Macdonald RL; Dong M; Kang JQ
Epilepsia; 2020 Oct; 61(10):2301-2312. PubMed ID: 32944937
[TBL] [Abstract][Full Text] [Related]
5. Altered GABAA receptor expression in brainstem nuclei and SUDEP in Gabrg2(+/Q390X) mice associated with epileptic encephalopathy.
Xia G; P Pourali S; Warner TA; Zhang CQ; L Macdonald R; Kang JQ
Epilepsy Res; 2016 Jul; 123():50-4. PubMed ID: 27131289
[TBL] [Abstract][Full Text] [Related]
6. Differential molecular and behavioural alterations in mouse models of GABRG2 haploinsufficiency versus dominant negative mutations associated with human epilepsy.
Warner TA; Shen W; Huang X; Liu Z; Macdonald RL; Kang JQ
Hum Mol Genet; 2016 Aug; 25(15):3192-3207. PubMed ID: 27340224
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.
Kang JQ; Macdonald RL
JAMA Neurol; 2016 Aug; 73(8):1009-16. PubMed ID: 27367160
[TBL] [Abstract][Full Text] [Related]
8. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.
Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S
Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790
[TBL] [Abstract][Full Text] [Related]
9. De novo GABRG2 mutations associated with epileptic encephalopathies.
Shen D; Hernandez CC; Shen W; Hu N; Poduri A; Shiedley B; Rotenberg A; Datta AN; Leiz S; Patzer S; Boor R; Ramsey K; Goldberg E; Helbig I; Ortiz-Gonzalez XR; Lemke JR; Marsh ED; Macdonald RL
Brain; 2017 Jan; 140(1):49-67. PubMed ID: 27864268
[TBL] [Abstract][Full Text] [Related]
10. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
[TBL] [Abstract][Full Text] [Related]
11. The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration.
Kang JQ; Shen W; Zhou C; Xu D; Macdonald RL
Nat Neurosci; 2015 Jul; 18(7):988-96. PubMed ID: 26005849
[TBL] [Abstract][Full Text] [Related]
12. Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome.
Poliquin S; Nwosu G; Randhave K; Shen W; Flamm C; Kang JQ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731820
[TBL] [Abstract][Full Text] [Related]
13. Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype.
Kang JQ; Shen W; Macdonald RL
Ann Neurol; 2013 Oct; 74(4):547-59. PubMed ID: 23720301
[TBL] [Abstract][Full Text] [Related]
14. Rescue of deficient amygdala tonic γ-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel γ-aminobutyric acid type A receptor-positive allosteric modulator.
Martin BS; Martinez-Botella G; Loya CM; Salituro FG; Robichaud AJ; Huntsman MM; Ackley MA; Doherty JJ; Corbin JG
J Neurosci Res; 2016 Jun; 94(6):568-78. PubMed ID: 26308557
[TBL] [Abstract][Full Text] [Related]
15. Mice harboring the T316N variant in the GABA
Jiang YL; Xia L; Zhao JJ; Zhou HM; Mi D; Wang X; Wang YY; Song CG; Jiang W
Exp Neurol; 2024 Jun; 376():114775. PubMed ID: 38604438
[TBL] [Abstract][Full Text] [Related]
16. Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.
Huang X; Hernandez CC; Hu N; Macdonald RL
Neurobiol Dis; 2014 Aug; 68():167-79. PubMed ID: 24798517
[TBL] [Abstract][Full Text] [Related]
17. GABA and epileptogenesis: comparing gabrb3 gene-deficient mice with Angelman syndrome in man.
DeLorey TM; Olsen RW
Epilepsy Res; 1999 Sep; 36(2-3):123-32. PubMed ID: 10515160
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effect of stiripentol in Gabrg2
Warner TA; Smith NK; Kang JQ
Epilepsy Res; 2019 Aug; 154():8-12. PubMed ID: 31022638
[TBL] [Abstract][Full Text] [Related]
19. The intronic GABRG2 mutation, IVS6+2T->G, associated with childhood absence epilepsy altered subunit mRNA intron splicing, activated nonsense-mediated decay, and produced a stable truncated γ2 subunit.
Tian M; Macdonald RL
J Neurosci; 2012 Apr; 32(17):5937-52. PubMed ID: 22539854
[TBL] [Abstract][Full Text] [Related]
20. Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.
Colangeli R; Morena M; Pittman QJ; Hill MN; Teskey GC
J Neurosci; 2020 Jul; 40(31):6068-6081. PubMed ID: 32601243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]